Project Grant HT94252410707
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$393K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68198, USA
Similar Awards
The federal Project Grant award of $848,335.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program supports a research initiative titled "NOVEL THERAPEUTIC APPROACH TO PREVENT UVEAL MELANOMA PROGRESSION" at the University of Nebraska Medical Center (UNMC). This 3-year award, running from August 1, 2025 to July 31, 2028, will fund advanced biomedical research aimed at transforming healthcare for military service members,...
The federal Project Grant award of $846,220 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to the Board of Regents of the University of Nebraska Medical Center (UNMC) on March 1, 2024. The award supports a 3-year research project titled "The Role of Astrocyte in Sleep Impairments in ASD" that aims to investigate the link between astrocyte function and sleep disturbances in individuals with autism spectrum...
The University of Nebraska Medical Center (UNMC) was awarded a $1,544,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a "NOVEL ER STRESS MITIGATION PATHWAY IN ERBB2-DRIVEN ONCOGENESIS". The grant, which has a performance period from May 1, 2024 to April 30, 2027, will support UNMC's investigation of an innovative pathway for mitigating endoplasmic reticulum (ER) stress in ErbB2-driven...
This federal Project Grant award for $772,501.00, awarded on May 1, 2024 by the Defense Health Agency, supports the University of Nebraska Medical Center's research project titled "BUTYRYLCHOLINESTERASE: AN OUTSTANDING DIAGNOSTIC AND DRUGGABLE BIOMARKER IN UVEAL MELANOMA." The project, funded under the Military Medical Research and Development program (CFDA 12.420), aims to advance research into butyrylcholinesterase as a diagnostic and therapeutic target for uveal melanoma, a rare and...
This $426,400 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of Chicago to conduct nanoscale structural and molecular mapping of the optic nervous system following ocular blast. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing understanding of the impact of ocular blast injuries on the nervous system. The award...
This federal Project Grant award of $183,220.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research at the University of Nebraska Medical Center (UNMC) to target the CCL17/CCR4 axis to eradicate lung cancer brain metastasis. The award, which began on February 1, 2025 and will be completed by January 31, 2026, aims to advance biomedical research that transforms healthcare for military service members, veterans, and the broader...
The Defense Health Agency awarded a $602,814 Project Grant to the University of Nebraska Medical Center (UNMC) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from November 1, 2024 to October 31, 2027, supports research to investigate "Targeting Extracellular Nucleoside Metabolism as a Strategy to Potentiate the Effects of Immunotherapy in Pancreatic Ductal Adenocarcinoma." The project aims to explore innovative approaches...
The U.S. Defense Health Agency awarded a $1,759,295 Project Grant under the Military Health Services Research (MHSR) Program (CFDA 12.007) to the University of Nebraska Medical Center (UNMC) on September 30, 2024. The grant is for a 2-year project to measure and monitor the global disease burden of active duty women, including reproductive health. UNMC will collaborate with the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. on this research effort through a $654,555...
The U.S. Defense Health Agency awarded a $1,489,045 project grant to The Ohio State University under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)", supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The research aims to investigate medical solutions for battlefield and other neurotrauma-related vision impairments. This 4-year award,...
The Defense Health Agency awarded a $498,896 Project Grant through the Military Medical Research and Development program (CFDA 12.420) to The Schepens Eye Research Institute, Inc. in Boston, MA. The grant supports a 2-year research project investigating the use of noninvasive transpalpebral electrical stimulation as a therapy for combat-related corneal trauma. As an experienced performer of prior federal grants from agencies like the NIH, DoD, and Army, the non-profit Schepens Eye Research...